How many of us have heard or experienced waiting in lines to see a doctor, receiving a misdiagnosis, months of searching for the right specialist, and feeling powerless about it? In the case of rare diseases or neoplasms, the diagnostic process takes up to 7 years from the first symptoms to appear. Sometimes it is too late for a sick patient because only 1 in 8 patients is properly diagnosed and treated because from 7000 rare diseases only 10% of them have a treatment. Now the diagnostics process of rare diseases is complex, far from optimal and the problem has been neglected for many years even in developed countries.
Fortunately, the development of medicine and science allows for the improvement and cooperation of these two sectors. Even from an epidemiological point of view, a Google search engine that was not designed for it was able to identify the symptoms of COVID-19 before its infection surged and was recognized by doctors. According to Dr Elena Ivanina, a gastroenterologist at Lenox Hill Hospital:
“This is not the first time Google searches have been used to predict epidemics”
If a device not intended for the diagnosis of diseases can work wonders, you can only imagine what effects we will get with Saventic.
Saventic is a company dealing in the diagnosis of rare diseases based on artificial intelligence, it creates comprehensive solutions to support healthcare systems. Saventic offers two platforms based on SARAH which uses AI algorithms with different diagnostic approaches on two levels of use: first – Saventic Medical API for clinics, hospitals or professional medical units and second – Saventic Foundation which is a new idea, a platform for patients that offers the possibility of a private diagnosis of rare diseases.
Saventic Medical API is a B2B opportunity for healthcare providers to make correct diagnoses in a faster and easier way. Also improvement not only in the diagnosis but also in the treatment of less common diseases and in area of knowledge about their symptoms or course of illness based on the collected data. The Foundation is a B2C application for patients seeking diagnosis. This is the second way to reach patients with rare diseases, not only to analyze databases in hospitals, but also directly to patients. The Foundation is currently supporting patients with metabolic and blood diseases, solutions for other diseases are under development. Algorithms for Gaucher’s disease, Fabry’s disease and blood cancer are currently being commercialized.
To sum up everything that has been stated so far from year to year, organizations such as Saventic will improve the work of doctors and disease diagnosis, as well as improve treatment methods and knowledge of their symptoms. Such a modern medical solution is a novelty on the Polish and global market.